John C. Pottage Jr serves as Executive at Spero Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, John C. Pottage Jr has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on May 29, 2024 involved receiving (via award) 20,000 shares valued at $0.
John C. Pottage Jr currently holds 55,000 shares of Spero Therapeutics, Inc. (SPRO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John C. Pottage Jr has been a net neutral trader of SPRO stock. They have purchased $0 and sold $0 worth of shares.
John C. Pottage Jr's most recent insider trade was on May 29, 2024, when they sold 20,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Sep 15, 2022 | SPRO | $0 | Award | 15,000 | $N/A | Discretionary |